CN112614576A - Method and system for tracing medicine source based on block chain technology - Google Patents

Method and system for tracing medicine source based on block chain technology Download PDF

Info

Publication number
CN112614576A
CN112614576A CN202011572859.1A CN202011572859A CN112614576A CN 112614576 A CN112614576 A CN 112614576A CN 202011572859 A CN202011572859 A CN 202011572859A CN 112614576 A CN112614576 A CN 112614576A
Authority
CN
China
Prior art keywords
information
production
medicine
block chain
time period
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011572859.1A
Other languages
Chinese (zh)
Inventor
贺复生
刘彦涛
陈圣爱
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aisino Corp
Original Assignee
Aisino Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aisino Corp filed Critical Aisino Corp
Priority to CN202011572859.1A priority Critical patent/CN112614576A/en
Publication of CN112614576A publication Critical patent/CN112614576A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/20ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q30/00Commerce
    • G06Q30/018Certifying business or products
    • G06Q30/0185Product, service or business identity fraud

Landscapes

  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Entrepreneurship & Innovation (AREA)
  • Economics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Accounting & Taxation (AREA)
  • Development Economics (AREA)
  • Epidemiology (AREA)
  • Finance (AREA)
  • Marketing (AREA)
  • Strategic Management (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

The invention relates to a method and a system for tracing a medicine source based on a block chain technology, wherein the method comprises the following steps: determining production position information of the target medicine, and generating an initial hash code based on the characteristic information and the production position information of each production time period; generating a blockchain time code of each production time period according to the initial hash code, and storing the characteristic information and the production position information which are subjected to content combination and the blockchain time code in a blockchain in a correlation mode; storing the quality information, the packaging information and the blockchain product code in a blockchain in a correlated manner, wherein the blockchain product code is used for identifying an identifier of each medicine unit, and the identifier in each medicine unit is marked on a packaging box of the medicine unit; the method includes forming a plurality of drug units into a drug group, obtaining location information for a sealed package and storing the location information in a blockchain in association with an identifier for each drug unit.

Description

Method and system for tracing medicine source based on block chain technology
Technical Field
The present invention relates to the field of blockchain technology, and more particularly, to a method and system for tracing a medicine source based on blockchain technology.
Background
The block chain technology is a technical scheme which is independent of a third party and performs storage, verification, transmission and communication of network data through self distributed nodes, and has the characteristics of decentralization, openness, independence, safety, anonymity and the like. The whole process of value transfer can be recorded completely and in a non-tampering way through the block chain, so that the credibility problem of data recording and transaction process can be solved. Based on the block chain technology, all relevant parties in the processes of examining, approving, producing, circulating, inoculating and the like of the vaccine can be linked up, the information of each transaction link is tracked and recorded in the whole process, a traceable safe inoculation credit system is constructed by five codes of a vaccine identification code, a cold chain equipment code, a audience code, an inoculation unit code and an inoculation doctor code, and the traceable safe inoculation credit system is realized, so that the reliable source, the non-falsification, the whole-process supervision, the human-vaccine correlation, the code scanning inoculation and the credible traceability are realized. When a certain link has a problem, the vaccine can be accurately positioned and quickly traced, so that convenience is brought to vaccine supervision, and public health is guaranteed.
And linking the data of the links of vaccine production, cold chain storage, cold chain distribution and inoculation based on the block chain technology, preventing data tampering and verifying the authenticity of the chain data.
The block chain is formed by butt joint of a space information block chain basic system serving as a bottom system and a vaccine tracing supervisory system. And the production data of the vaccine, the code data of the drug supervision code, the storage and distribution data, the inoculation data, the AEFI (adverse reaction) data and the effect evaluation data are subjected to chain storage, so that the authenticity of marketing data is ensured. The risk of artificially tampering vaccine information is reduced. According to the characteristics of vaccine or vaccine supervision business, a credible, controllable and extensible vaccine supervision block chain is established, the problem that the local area network architecture applied by the block chain is high in cost at present is solved, the development, deployment, operation and maintenance, intercommunication and supervision costs of the block chain application are reduced, and the block chain is rapidly popularized and developed in vaccine supervision.
By utilizing a blockchain and Internet of things technology, traceability and non-tampering of the whole vaccine production process are realized, and the trust problem in the traditional traceability system is solved; under a consensus mechanism, all parties participating in the vaccine ecological chain carry out cooperative supervision on the whole chain to prevent ' unique ' dark box operation '; the block chain intelligent contract realizes real-time supervision, the problems are tracked in real time, and effective responsibility tracing is realized, so that common people are relieved; and storing the Hash chain of the vaccine full life cycle data, and verifying the obtained vaccine data by a monitoring party and the public through a verification contract.
The existing vaccine tracing and supervising methods all have certain defects. The basic and innovative research of the vaccine tracing and supervising method is carried out only by taking the national collaboration platform as a hand grip as an entry point due to the unfamiliarity of the drug supervising business and the unfamiliarity of the informatization construction field.
Disclosure of Invention
The invention utilizes advanced technologies such as Internet of things and big data, focuses on developing a public service platform and supporting equipment with government public credibility, introduces an aerospace information block chain technology to be applied to a vaccine tracing supervision platform, firstly realizes the tamper resistance of vaccines from production, cold chain distribution and inoculation full chain data, and has traceable evidence chain. The technical architecture adopts a micro-service architecture, and is convenient for deployment, transplantation, cross-platform development and functional module utilization. .
According to one aspect, there is provided a method for drug tracing based on blockchain technology, the method comprising:
selecting a target medicine needing tracing from a plurality of medicines, determining description information of each production time period in a plurality of production time periods of the target medicine, and performing feature extraction on the description information of each production time period to acquire feature information of each production time period;
determining production position information of the target medicine, and generating an initial hash code based on the characteristic information and the production position information of each production time period;
generating a blockchain time code of each production time period according to the initial hash code, and storing the characteristic information and the production position information which are subjected to content combination and the blockchain time code in a blockchain in an associated manner, wherein the blockchain time code is used for identifying each production time period of the target medicine;
determining first quality information and packaging information of each medicine in a production time period, generating a product hash code based on the quality information and the packaging information, generating a block chain product code based on the product hash code, and storing the quality information, the packaging information and the block chain product code into a block chain in an associated manner, wherein the block chain product code is used for identifying an identifier of each medicine unit, and the identifier in each medicine unit is marked on a packing box of the medicine unit;
the method includes the steps of forming a plurality of medicine units into a medicine group, providing a non-detachable sealed package for the medicine group and a satellite positioning component in the sealed package, acquiring position information of the sealed package and storing the position information in a block chain in association with an identifier of each medicine unit.
The description information includes: production party information, production qualification information, license information, raw material supplier information, and production equipment information.
The quality information includes: information for describing quality level
The package information includes: specification information and packaging material information.
When a source tracing request for a specific medicine monomer is received, the quality information, the packaging information, the characteristic information and the production position information of the medicine monomer are acquired from the block chain based on the identifier of the medicine monomer.
The extracting the feature of the description information of each production time slot to obtain the feature information of each production time slot comprises the following steps:
segmenting the description information of each production time period to obtain a plurality of words;
selecting nouns in the plurality of words as candidate words to obtain a plurality of candidate words;
determining a record entry of each candidate word in a medicine information database;
selecting candidate words with the record items larger than a preset number as characteristic words; and
and taking a word set of at least one characteristic word as characteristic information of each production time period.
According to another aspect, a system for drug tracing based on block chain technology is provided, the system comprising:
the selection device selects a target medicine to be traced from a plurality of medicines, determines the description information of each production time period in a plurality of production time periods of the target medicine, and performs feature extraction on the description information of each production time period to acquire the feature information of each production time period;
the production device is used for determining the production position information of the target medicine and generating an initial hash code based on the characteristic information and the production position information of each production time period;
the storage device generates a block chain time code of each production time period according to the initial hash code, and stores the characteristic information and the production position information which are subjected to content combination and the block chain time code in a block chain in an associated manner, wherein the block chain time code is used for identifying each production time period of the target medicine;
the labeling device is used for determining first quality information and first packaging information of each medicine in a production time period, generating a product hash code based on the quality information and the packaging information, generating a block chain product code based on the product hash code, and storing the quality information, the packaging information and the block chain product code into a block chain in an associated mode, wherein the block chain product code is used for identifying an identifier of each medicine unit, and the identifier in each medicine unit is labeled on a packaging box of the medicine unit;
the system comprises a composition device for composing a plurality of medicine monomers into a medicine group, arranging a non-detachable sealed package for the medicine group and arranging a satellite positioning component on the sealed package, acquiring position information of the sealed package and storing the position information in a block chain in association with an identifier of each medicine monomer.
The description information includes: production party information, production qualification information, license information, raw material supplier information, and production equipment information.
The quality information includes: information for describing quality level
The package information includes: specification information and packaging material information.
When a source tracing request for a specific medicine monomer is received, the quality information, the packaging information, the characteristic information and the production position information of the medicine monomer are acquired from the block chain based on the identifier of the medicine monomer.
The extracting the feature of the description information of each production time slot to obtain the feature information of each production time slot comprises the following steps:
segmenting the description information of each production time period to obtain a plurality of words;
selecting nouns in the plurality of words as candidate words to obtain a plurality of candidate words;
determining a record entry of each candidate word in a medicine information database;
selecting candidate words with the record items larger than a preset number as characteristic words; and
and taking a word set of at least one characteristic word as characteristic information of each production time period.
The vaccine retrospective supervision method based on the block chain technology has three characteristics: firstly, the credible tracing is realized by using a new technology of a block chain around the implementation and construction of the newly established vaccine information tracing standard; secondly, the medicine supervision is taken as the leading factor, and the health and disease control departments are in full cooperation, so that the full-ring data communication of production, circulation and use is realized, and meanwhile, the communication with the national platform is also realized; and thirdly, the method covers all links of production, transportation, storage, distribution and inoculation, covers production enterprises, circulation enterprises, disease control organizations, inoculation doctors and audiences, can serve the public and makes beneficial attempts for national platform construction. The vaccine supervision system records relevant information of vaccine product production enterprises, entrusted distribution enterprises, disease control centers, vaccination units, vaccinated children and the like through the whole block chain process, and writes dynamic information (timestamps, positions, temperatures and the like) in the vaccine circulation process into the block chain, so that traceability of the whole vaccine process, reliable data sources and penetrating supervision of a supervision party are realized.
The key points of the technology of the invention are as follows:
1. the whole process tracing system for vaccine production is realized by using a 'block chain + Internet of things' technology;
2. the block chain technology is used for realizing decentralized supervision, and a long-acting mechanism for vaccine safety management is formed. By utilizing a blockchain and Internet of things technology, traceability and non-tampering of the whole vaccine production process are realized, and the trust problem in the traditional traceability system is solved; under a consensus mechanism, all parties participating in the vaccine ecological chain carry out cooperative supervision on the whole chain to prevent ' unique ' dark box operation '; the block chain intelligent contract realizes real-time supervision, the problems are tracked in real time, and effective responsibility tracing is realized, so that common people are relieved; and storing the Hash chain of the vaccine full life cycle data, and verifying the obtained vaccine data by a monitoring party and the public through a verification contract.
3. Micro-service technology is introduced. The vaccine tracing supervision service is packaged into components, so that the rapid fusion with other platforms can be realized, the cross-platform calling can be realized, and the advantages of rapid deployment, rapid upgrading and non-stop service upgrading system implementation of projects are improved. This model provides a modular solution to functions that are difficult to implement using monolithic coding, whereby a single service is easy to develop, understand and maintain. And due to the characteristics of the API, the development technology can be freely selected to provide the API service. The system is better butted with various systems, each micro service is independently deployed by the micro service architecture mode, and the influence of other service deployment on the service is not needed to be coordinated. Such changes may speed deployment, making continued deployment possible. Finally, this architectural model allows each service to be extended independently. We deploy benefits that meet the demand according to the size of each service. Even more, we can use hardware that is more suited to the service resource requirements.
4. And a big data acquisition and deep mining technology is introduced to provide medication safety, habit and health condition model analysis for a supervision department.
5. And services such as intelligent pushing of inspection items, intelligent pushing of problems and the like are realized by utilizing an artificial intelligence technology.
6. And establishing cloud service, and providing intelligent self-checking autonomous service support for enterprise users.
The beneficial effects of the invention include: the invention is based on the construction thought of a national vaccine informatization tracing system, a platform leads all links of vaccine production, circulation and inoculation to be opened, relevant data specifications are constructed, comprehensive opening with an enterprise tracing supervision system, a cold-chain logistics storage company management system and a preventive inoculation system is realized, a vaccine tracing supervision platform and three subsystems facing the public, vaccine production enterprises and supervision personnel are constructed, and finally, the whole process data of the vaccine is opened to the public, and the confidence and the obtainment sense of the public on the safety of the vaccine are provided. By depending on an aerospace information block chain and a big data technology, a new generation of drug tracing and supervision cooperative platform is researched on the basis of a vaccine tracing and supervision platform in Tianjin city, vaccine full-chain tracing and supervision cooperation are covered, and a smart vaccine service cloud which provides accurate supervision and enterprise self-checking and autonomous services for drug supervision departments and vaccine production enterprises is provided.
Meanwhile, the research of the invention is based on vaccine production and sales data, analyzes analysis services such as user medication habits, health conditions and aggregated diseases, and provides data support for vaccine storage, emergency allocation and the like. The block chain technology-based drug (vaccine) tracing platform is researched and developed, block chain service is established, and all link data are linked up from vaccine production, transportation and use, so that the whole course of traceable data is truly traceable. The public can inquire the whole-link data of each vaccine and each batch of vaccines through a traceability system chain. The big data analysis technology is introduced, online service is provided for the inspection items of the supervision personnel through big data analysis, and the supervision personnel are intelligently guided to carry out inspection. By providing intelligent self-checking assistance for enterprise personnel according to the standard requirements, the self-checking capability of the enterprise is improved, and a social co-treatment system is established.
Drawings
A more complete understanding of exemplary embodiments of the present invention may be had by reference to the following drawings in which:
fig. 1 is a flowchart of a method for tracing a medicine source based on a block chain technique according to an embodiment of the present invention;
fig. 2 is a schematic structural diagram of a system for performing drug tracing based on a block chain technique according to an embodiment of the present invention.
Detailed Description
Fig. 1 is a flowchart of a method for tracing a medicine source based on a block chain technique according to an embodiment of the present invention. The method 100 comprises:
step 101, selecting a target drug to be traced from a plurality of drugs, determining description information of each production time period in a plurality of production time periods of the target drug, and performing feature extraction on the description information of each production time period to acquire feature information of each production time period.
Step 102, determining production position information of the target medicine, and generating an initial hash code based on the characteristic information and the production position information of each production time period.
And 103, generating a blockchain time code of each production time slot according to the initial hash code, and storing the characteristic information and the production position information which are subjected to content combination and the blockchain time code in a blockchain in an associated manner, wherein the blockchain time code is used for identifying each production time slot of the target medicine.
And 104, determining first quality information and first packaging information of each medicine in the production time period, generating a product hash code based on the quality information and the packaging information, generating a blockchain product code based on the product hash code, and storing the quality information, the packaging information and the blockchain product code into a blockchain in an associated manner, wherein the blockchain product code is used for identifying an identifier of each medicine unit, and the identifier in each medicine unit is marked on a packaging box of the medicine unit.
Step 105, forming a plurality of medicine monomers into a medicine group, arranging a non-detachable sealed package for the medicine group and arranging a satellite positioning component on the sealed package, acquiring position information of the sealed package and storing the position information in a block chain in association with an identifier of each medicine monomer.
The description information includes: production party information, production qualification information, license information, raw material supplier information, and production equipment information.
The quality information includes: information for describing quality level
The package information includes: specification information and packaging material information.
When a source tracing request for a specific medicine monomer is received, the quality information, the packaging information, the characteristic information and the production position information of the medicine monomer are acquired from the block chain based on the identifier of the medicine monomer.
The extracting the feature of the description information of each production time slot to obtain the feature information of each production time slot comprises the following steps:
segmenting the description information of each production time period to obtain a plurality of words;
selecting nouns in the plurality of words as candidate words to obtain a plurality of candidate words;
determining a record entry of each candidate word in a medicine information database;
selecting candidate words with the record items larger than a preset number as characteristic words; and
and taking a word set of at least one characteristic word as characteristic information of each production time period.
In the small and medium-scale software, the object and the cooperation relation between the objects can meet the requirement. However, as software scales up and complexity increases, the cooperation emphasized by object-oriented technology shows another extreme characteristic — complexity caused by too high coupling. There is a need for a new approach to remedy the weaknesses of object-oriented technology. Large-scale software is primarily characterized by complexity. A more typical example is an item of integration. Software systems need to integrate a wide variety of hardware, legacy systems, external interfaces. Different hardware interfaces, different operating systems, different languages, different platforms, different databases, different message middleware, and different network media may be encountered. These all make the system very complex. The abbreviation for component programming is COP. COP is a complement to OOP, helping to achieve a more excellent software structure. The granularity of the components may be large or small, depending on the particular application. The COP idea is adopted, the system is regarded as individual components, and the construction of the system is completed by defining the cooperation relationship (through services) among the components. This has the advantage of isolating changes, making the system reasonably partitioned. The meaning of a framework is to define the way in which components are organized.
The micro-service technology is introduced, vaccine tracing supervision services are packaged into components, rapid fusion with other platforms and cross-platform calling can be realized, and the advantages of rapid deployment, rapid upgrading and non-stop service upgrading system implementation of project implementation are improved.
This model provides a modular solution to functions that are difficult to implement using monolithic coding, whereby a single service is easy to develop, understand and maintain. And due to the characteristics of the API, the development technology can be freely selected to provide the API service. The system is better butted with various systems, each micro service is independently deployed by the micro service architecture mode, and the influence of other service deployment on the service is not needed to be coordinated. Such changes may speed deployment, making continued deployment possible. Finally, this architectural model allows each service to be extended independently. We deploy benefits that meet the demand according to the size of each service. Even more, we can use hardware that is more suited to the service resource requirements.
And linking the data of the links of vaccine production, cold chain storage, cold chain distribution and inoculation based on the block chain technology, preventing data tampering and verifying the authenticity of the chain data. The block chain is formed by butt joint of a space information block chain basic system serving as a bottom system and a vaccine tracing supervisory system. And the production data of the vaccine, the code data of the drug supervision code, the storage and distribution data, the inoculation data, the AEFI (adverse reaction) data and the effect evaluation data are subjected to chain storage, so that the authenticity of marketing data is ensured. The risk of artificially tampering vaccine information is reduced. According to the characteristics of vaccine or vaccine supervision business, a credible, controllable and extensible vaccine supervision block chain is established, the problem that the local area network architecture applied by the block chain is high in cost at present is solved, the development, deployment, operation and maintenance, intercommunication and supervision costs of the block chain application are reduced, and the block chain is rapidly popularized and developed in vaccine supervision.
By utilizing a blockchain and Internet of things technology, traceability and non-tampering of the whole vaccine production process are realized, and the trust problem in the traditional traceability system is solved; under a consensus mechanism, all parties participating in the vaccine ecological chain carry out cooperative supervision on the whole chain to prevent ' unique ' dark box operation '; the block chain intelligent contract realizes real-time supervision, the problems are tracked in real time, and effective responsibility tracing is realized, so that common people are relieved; and storing the Hash chain of the vaccine full life cycle data, and verifying the obtained vaccine data by a monitoring party and the public through a verification contract.
Vaccine data are collected from different links, various risks are analyzed to supervisors through filtering, analysis and deep mining, the supervisors can do corresponding treatment in advance, and risks of various links of the vaccine are reduced.
A layered design module: the design comprises an application layer, a framework layer and a basic layer, and the code or variable at the topmost layer can cover the lower layer;
and (3) compression and packaging: after the resource codes are processed through the FIS plug-in, the resource codes are packaged into an installation package through a Cordova tool;
the overall components are as follows: providing comprehensive components comprising a container class, a form class and the like;
commonly used plug-ins: providing a common plug-in for calling the functions of the native device, and using the plug-in once through one-key installation;
rich services: providing rich service interfaces to call projects;
online documentation supports: the online documents include API views, sample presentations, novice directions, and other descriptive documents.
By adopting the technical scheme, if vaccine problems occur, the arteries and veins of the vaccine with the problems can be easily checked. And (4) using the Internet of things to punch an RFID label on each vaccine. Only a reader is needed to sweep, and relevant information is recorded or read, so that the workload is greatly reduced. In addition, the block chain technology adopts a multi-center or centerless system, and a central processor does not exist, so that data is difficult to tamper or delete. The national drug administration for the approval of vaccine production, the vaccine-producing enterprises, the vaccine-selling distributors, the vaccine-purchasing disease control centers at all levels, hospitals, and finally vaccine users are all incorporated into this system. Before a vaccine is qualified through production inspection and is ready to be put on the market, a manufacturer firstly inputs the vaccine into a system. With the circulation of vaccines in marketing activities, the system is entered at each step. Finally, all information within this system can be shared by the various entities, except the final vaccine user, entered by the hospital using the vaccine. Problems with the vaccine can be easily ascertained by the system as to which units and individuals have taken the vaccine and at which stage problems may occur. If a problem is found with a certain batch of vaccine, it is also convenient to find out which consumers used the batch of vaccine.
According to the method, an industry public chain is designed according to the characteristics of the vaccine and pharmaceutical industry, after an enterprise adopts the chain, the production flow of each product can be inquired, each product has a unique two-dimensional code, and any person can check all links from production, to a distributor and to transportation by using a mobile phone. Vaccine data need combine artificial intelligence and big data technology, integrate the data and classify, public chain of block chain vaccine, and data no longer rely on artifical record, but upload in real time, have avoided the record to make the fake problem, and the quality has the problem to ensure to discover very first time.
The block chain technology is used for realizing decentralized supervision, and a long-acting mechanism for vaccine safety management is formed. Data on an enterprise production line is linked up in real time, and any person can check the data at any time and cannot tamper, so that tampering of original data is avoided, supervision and inspection are avoided, and the occurrence of things damaging the society is avoided. With the blockchain decentralized, no officer can be right to rent, including industry experts, media reporters, competitors, and even ordinary people, can view the relevant data at any time. Meanwhile, government agencies need to monitor the production and use of vaccines more powerfully, and need to 'punch and disorder' illegal production and operation behaviors, so that industry development is standardized by stricter production standards, stricter normal monitoring and more serious illegal punishment, and the trust of the public on the vaccines is guaranteed.
Fig. 2 is a schematic structural diagram of a system for performing drug tracing based on a block chain technique according to an embodiment of the present invention. The system 200 includes: a selection device 201, a production device 202, a storage device 203, a labeling device 204, and a composition device 205.
The selection device 201 selects a target drug to be traced from a plurality of drugs, determines description information of each production time period in a plurality of production time periods of the target drug, and performs feature extraction on the description information of each production time period to acquire feature information of each production time period.
The production device 202 determines production location information of the target pharmaceutical product, and generates an initial hash code based on the characteristic information and the production location information for each production time period.
The storage device 203 generates a blockchain time code for each production time period according to the initial hash code, and stores the characteristic information and the production position information which are subjected to content combination and the blockchain time code in the blockchain in an associated manner, wherein the blockchain time code is used for identifying each production time period of the target medicine.
And the labeling device 204 is used for determining first quality information and first packaging information of each medicine in the production time period, generating a product hash code based on the quality information and the packaging information, generating a blockchain product code based on the product hash code, and storing the quality information, the packaging information and the blockchain product code into a blockchain in an associated mode, wherein the blockchain product code is used for identifying an identifier of each medicine unit, and the identifier in each medicine unit is labeled on a packing box of the medicine unit.
A composing means 205 composing a plurality of medicine units into a medicine group, providing a non-detachable sealed package for the medicine group and a satellite positioning component at the sealed package, acquiring position information of the sealed package and storing the position information in the block chain in association with an identifier of each medicine unit.
The description information includes: production party information, production qualification information, license information, raw material supplier information, and production equipment information. The quality information includes: information describing the quality level. The package information includes: specification information and packaging material information. When a source tracing request for a specific medicine monomer is received, the quality information, the packaging information, the characteristic information and the production position information of the medicine monomer are acquired from the block chain based on the identifier of the medicine monomer.
The extracting the feature of the description information of each production time slot to obtain the feature information of each production time slot comprises the following steps:
segmenting the description information of each production time period to obtain a plurality of words;
selecting nouns in the plurality of words as candidate words to obtain a plurality of candidate words;
determining a record entry of each candidate word in a medicine information database;
selecting candidate words with the record items larger than a preset number as characteristic words; and
and taking a word set of at least one characteristic word as characteristic information of each production time period.

Claims (10)

1. A method for drug tracing based on blockchain technology, the method comprising:
selecting a target medicine needing tracing from a plurality of medicines, determining description information of each production time period in a plurality of production time periods of the target medicine, and performing feature extraction on the description information of each production time period to acquire feature information of each production time period;
determining production position information of the target medicine, and generating an initial hash code based on the characteristic information and the production position information of each production time period;
generating a blockchain time code of each production time period according to the initial hash code, and storing the characteristic information and the production position information which are subjected to content combination and the blockchain time code in a blockchain in an associated manner, wherein the blockchain time code is used for identifying each production time period of the target medicine;
determining first quality information and packaging information of each medicine in a production time period, generating a product hash code based on the quality information and the packaging information, generating a block chain product code based on the product hash code, and storing the quality information, the packaging information and the block chain product code into a block chain in an associated manner, wherein the block chain product code is used for identifying an identifier of each medicine unit, and the identifier in each medicine unit is marked on a packing box of the medicine unit;
the method includes the steps of forming a plurality of medicine units into a medicine group, providing a non-detachable sealed package for the medicine group and a satellite positioning component in the sealed package, acquiring position information of the sealed package and storing the position information in a block chain in association with an identifier of each medicine unit.
2. The method of claim 1, the description information comprising: production party information, production qualification information, license information, raw material supplier information, and production equipment information.
3. The method of claim 1, the quality information comprising: information describing the quality level.
4. The method of claim 1, the packaging information comprising: specification information and packaging material information.
5. The method according to claim 1, when a traceability request for a specific drug monomer is received, acquiring quality information, packaging information, characteristic information and production location information of the drug monomer from the block chain based on an identifier of the drug monomer.
6. A system for drug tracing based on blockchain technology, the system comprising:
the selection device selects a target medicine to be traced from a plurality of medicines, determines the description information of each production time period in a plurality of production time periods of the target medicine, and performs feature extraction on the description information of each production time period to acquire the feature information of each production time period;
the production device is used for determining the production position information of the target medicine and generating an initial hash code based on the characteristic information and the production position information of each production time period;
the storage device generates a block chain time code of each production time period according to the initial hash code, and stores the characteristic information and the production position information which are subjected to content combination and the block chain time code in a block chain in an associated manner, wherein the block chain time code is used for identifying each production time period of the target medicine;
the labeling device is used for determining first quality information and first packaging information of each medicine in a production time period, generating a product hash code based on the quality information and the packaging information, generating a block chain product code based on the product hash code, and storing the quality information, the packaging information and the block chain product code into a block chain in an associated mode, wherein the block chain product code is used for identifying an identifier of each medicine unit, and the identifier in each medicine unit is labeled on a packaging box of the medicine unit;
the system comprises a composition device for composing a plurality of medicine monomers into a medicine group, arranging a non-detachable sealed package for the medicine group and arranging a satellite positioning component on the sealed package, acquiring position information of the sealed package and storing the position information in a block chain in association with an identifier of each medicine monomer.
7. The system of claim 6, the description information comprising: production party information, production qualification information, license information, raw material supplier information, and production equipment information.
8. The system of claim 6, the quality information comprising: information describing the quality level.
9. The system of claim 6, the packaging information comprising: specification information and packaging material information.
10. The system of claim 6, upon receiving a traceability request for a specific drug unit, acquiring quality information, packaging information, characteristic information and production location information of the drug unit from the blockchain based on the identifier of the drug unit.
CN202011572859.1A 2020-12-25 2020-12-25 Method and system for tracing medicine source based on block chain technology Pending CN112614576A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011572859.1A CN112614576A (en) 2020-12-25 2020-12-25 Method and system for tracing medicine source based on block chain technology

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011572859.1A CN112614576A (en) 2020-12-25 2020-12-25 Method and system for tracing medicine source based on block chain technology

Publications (1)

Publication Number Publication Date
CN112614576A true CN112614576A (en) 2021-04-06

Family

ID=75247963

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011572859.1A Pending CN112614576A (en) 2020-12-25 2020-12-25 Method and system for tracing medicine source based on block chain technology

Country Status (1)

Country Link
CN (1) CN112614576A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113656408A (en) * 2021-08-19 2021-11-16 龙兴(杭州)航空电子有限公司 Full-life-cycle management method and system for aviation material based on RFID combined block chain technology

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113656408A (en) * 2021-08-19 2021-11-16 龙兴(杭州)航空电子有限公司 Full-life-cycle management method and system for aviation material based on RFID combined block chain technology

Similar Documents

Publication Publication Date Title
Lone et al. Forensic-chain: Blockchain based digital forensics chain of custody with PoC in Hyperledger Composer
US20210073736A1 (en) Computer implemented system and associated methods for management of workplace incident reporting
Bénaben et al. A metamodel for knowledge management in crisis management
CN111787090B (en) Intelligent treatment platform based on block chain technology
CN111125774A (en) Engineering safety supervision traceability system and method based on block chain intelligent contract
Suryantara et al. Development of Medical Record With Extreme Programming SDLC
CN105556552A (en) Fraud detection and analysis
CN109461008A (en) Drug Administration method and system based on block chain
CN109271382A (en) A kind of data lake system towards full data shape opening and shares
CN107818536B (en) Monitoring system and method for realizing community drug rehabilitation and rehabilitation based on intelligent mobile terminal
CN102663008B (en) Government integrated business platform business library and construction method of base library
US20150074036A1 (en) Knowledge management system
Dlodlo et al. The status of integration of health information systems in Namibia
CN113741909B (en) Micro-service deployment method and device, electronic equipment and storage medium
CN114078602A (en) System, method and application for realizing rapid tracing, screening and control of key crowds based on big data and AI technology in infectious disease prevention and control
CN114386986A (en) Product full life cycle data tracing platform
CN110472427A (en) A kind of whole with no paper agriculture site inspection or enforcement approach and system
CN111986794A (en) Anti-counterfeiting registration method and device based on face recognition, computer equipment and medium
CN109784956A (en) Agricultural product source tracing method based on block chain technology
CN112614576A (en) Method and system for tracing medicine source based on block chain technology
Sahay et al. Institutionalizing Information Systems for Universal Health Coverage in Primary Health Care and the Need for New Forms of Institutional Work
CN116957341A (en) Intelligent safety risk management and control system based on steel mill
Grijpink Chain analysis for large-scale communication systems: a methodology for information exchange in chains
Robertson et al. Healthcare data safe havens: towards a logical architecture and experiment automation
CN114764743A (en) Fire-fighting data processing method and intelligent fire-fighting platform

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination